Dialysis News and Research

Latest Dialysis News and Research

Person with type 2 diabetes may spend nearly $85,500 to treat the disease

A person with type 2 diabetes may spend an average of nearly $85,500 to treat the disease and its complications over his or her lifetime, reports a new study in the American Journal of Preventive Medicine.

9 Aug 2013

Viewpoints: GOP's shutdown vow; Peter Orszag defends rationale behind Medicare payment board

A dozen Republicans in the Senate have said they'd rather shut down the government than provide funding for the Patient Protection and Affordable Care Act, the 2010 healthcare reform law better known as Obamacare. Meanwhile, more than 60 Republicans in the House have called on their leadership to cut off all federal support for the law in the coming fiscal year. And they complain when President Obama doesn't hold up his end of the bargain? (7/30).

1 Aug 2013

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease and end-stage renal disease.

31 Jul 2013

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

Astellas Pharma Inc. (Tokyo:4503) (Astellas) and FibroGen, Inc. (FibroGen) announced today the initiation of a Phase 2 clinical study in Japan of ASP1517/FG-4592 for treatment of anemia associated with chronic kidney disease (CKD) in patients on dialysis.

31 Jul 2013

NIH expands CRIC study to identify risk factors for progression of early stage CKD

Researchers from the Chronic Renal Insufficiency Cohort study are embarking on another five years of work to identify risk factors for progression of early stage chronic kidney disease, better understand the importance of reduced kidney function in older persons, and learn what role CKD may play in other illnesses that require hospitalization. CRIC is supported by the National Institutes of Health.

30 Jul 2013

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

Both the frequency and duration of patient-doctor contact during dialysis care vary appreciably across countries, and facilities with more frequent and longer contact had fewer patient deaths and hospitalizations, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

26 Jul 2013

NxStage Medical revenue increases 11% to $65.5 million in Q2 2013

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported second quarter financial results with total revenue at the top end of its guidance range.

25 Jul 2013

Study shows obese kidney failure patients derive survival advantage from transplantation

Most obese individuals with kidney failure can prolong their lives by receiving a kidney transplant, although this survival benefit is lower in severely obese individuals. That's the conclusion of a new study published in the American Journal of Transplantation.

25 Jul 2013

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

A new study led by researchers at the University of Limerick’s Graduate Entry Medical School has found that deaths among dialysis patients are falling despite a rise in coronary artery disease.

24 Jul 2013

Detroit seeks retiree pension, health care cuts in Bankruptcy Filing

Detroit and its retirees begin a court fight this week over how much the city can cut its pension and health care benefits as it seeks to discharge $19 billion in debt.

23 Jul 2013

First Edition: July 22, 2013

Today's headlines include reports about the continuing efforts in opposition to the health law as well as a Washington Post investigation into a "flaw" in U.S. health care pricing.

22 Jul 2013

DaVita acquires dialysis operations of Malaysia's CDC Group

DaVita®, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced the acquisition of the dialysis operations of Malaysia's Caring Dialysis Centre Group by DVA (Malaysia) Sdn Bhd.

22 Jul 2013

ACC report helps clinicians optimize appropriate use of noninvasive vascular tests

A new report issued today by the American College of Cardiology (ACC) and developed in collaboration with 10 other leading professional societies provides detailed criteria to help clinicians optimize the appropriate use of certain noninvasive vascular tests when caring for patients with known or suspected disorders of the venous (veins) system.

20 Jul 2013

Par Pharmaceutical receives final ANDA approval for generic version of Trilipix

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fenofibric acid EQ 45 mg and EQ 135 mg delayed-release capsules.

19 Jul 2013

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.

18 Jul 2013

Healthcare system factors may play a role in racial disparities related to kidney failure

Among patients with kidney disease who received specialized pre-dialysis care in a universal healthcare system, blacks experienced faster disease progression than whites, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The findings suggest that healthcare system factors have less influence on black-white disparities in kidney function decline than other factors.

12 Jul 2013

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.

11 Jul 2013

Heart transplant could get a second chance to save life

Human hearts which are not used each year because they are deemed unsuitable for an organ transplant could get a second chance to save a life, with the help of new research taking place in the North East.

11 Jul 2013

Middle East respiratory syndrome coronavirus currently unlikely to cause a pandemic, finds study

New estimates of the transmissibility of the Middle East respiratory syndrome coronavirus (MERS-CoV) in humans suggest that it does not yet have pandemic potential, according to research published in The Lancet.

9 Jul 2013

Proposal to cut Medicare ESRD Program may have unintended consequences for people on dialysis

A proposal to cut the Medicare End-Stage Renal Disease (ESRD) Program by nearly 10% may have unintended consequences for people on dialysis. "More than 20 million Americans have kidney disease, and the Medicare ESRD program provides lifesaving care to nearly 400,000 beneficiaries with kidney failure," said Bruce A. Molitoris, MD, FASN, President of the American Society of Nephrology (ASN).

9 Jul 2013

Dialysis News and Research

Latest Dialysis News and Research

Person with type 2 diabetes may spend nearly $85,500 to treat the disease

Viewpoints: GOP's shutdown vow; Peter Orszag defends rationale behind Medicare payment board

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

FibroGen, Astellas initiate Phase 2 study of ASP1517/FG-4592 for treatment of anemia linked with CKD

NIH expands CRIC study to identify risk factors for progression of early stage CKD

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

NxStage Medical revenue increases 11% to $65.5 million in Q2 2013

Study shows obese kidney failure patients derive survival advantage from transplantation

Mortality rates declining among dialysis patients despite rise in coronary artery disease, study finds

Detroit seeks retiree pension, health care cuts in Bankruptcy Filing

First Edition: July 22, 2013

DaVita acquires dialysis operations of Malaysia's CDC Group

ACC report helps clinicians optimize appropriate use of noninvasive vascular tests

Par Pharmaceutical receives final ANDA approval for generic version of Trilipix

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Healthcare system factors may play a role in racial disparities related to kidney failure

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Heart transplant could get a second chance to save life

Middle East respiratory syndrome coronavirus currently unlikely to cause a pandemic, finds study

Proposal to cut Medicare ESRD Program may have unintended consequences for people on dialysis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in